Pharming Group N.V. (PHAR) stock
PHARNasdaqPharmaceutical PreparationsFiscal year ends December 31
$12.48+0.42 (+3.51%)
Close on Nov 18, 2026Market cap $875.92MP/E 312.1Yield –
Pharming free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
For fiscal 2025 it was $53.96M. The highest annual figure on record is $78.97M in fiscal 2020.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $53.96M | – |
| FY2024 | Dec 31, 2024 | -$2.59M | – |
| FY2023 | Dec 31, 2023 | -$18.74M | -188.9% |
| FY2022 | Dec 31, 2022 | $21.08M | -22.2% |
| FY2021 | Dec 31, 2021 | $27.10M | -65.7% |
| FY2020 | Dec 31, 2020 | $78.97M | +10.4% |
| FY2019 | Dec 31, 2019 | $71.50M | – |
See a number that looks wrong?